| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.063 | 0.3 |